S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80

Align Technology Stock Forecast, Price & News

+0.23 (+0.10%)
(As of 06/29/2022 05:48 PM ET)
Today's Range
50-Day Range
52-Week Range
840,557 shs
Average Volume
1.03 million shs
Market Capitalization
$19.08 billion
P/E Ratio
Dividend Yield
Price Target
30 days | 90 days | 365 days | Advanced Chart

Receive ALGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Align Technology and its competitors with MarketBeat's FREE daily newsletter.

ALGN Stock Forecast (MarketRank)

Overall MarketRank

2.70 out of 5 stars

Medical Sector

64th out of 1,432 stocks

Surgical Appliances & Supplies Industry

4th out of 30 stocks

Analyst Opinion: 3.5Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 1.9 5 -4 -3 -2 -1 -
Align Technology logo

About Align Technology (NASDAQ:ALGN)

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

ALGN Stock News Headlines

Align Technology (NASDAQ:ALGN) Price Target Cut to $479.00
What 5 Analyst Ratings Have To Say About Align Tech
Are Investors Repeating Mistakes They Made in 2020?
See More Headlines

Industry, Sector and Symbol

Surgical appliances & supplies
Health Care Supplies
Current Symbol
Year Founded

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
11 Analysts


Net Income
$772.02 million
Pretax Margin


Sales & Book Value

Annual Sales
$3.95 billion
Cash Flow
$10.45 per share
Book Value
$45.94 per share


Free Float
Market Cap
$19.08 billion

Social Links

Align Technology Frequently Asked Questions

Should I buy or sell Align Technology stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Align Technology stock.
View analyst ratings for Align Technology
or view top-rated stocks.

What is Align Technology's stock price forecast for 2022?

11 brokerages have issued 1 year price targets for Align Technology's stock. Their ALGN stock forecasts range from $418.00 to $810.00. On average, they predict Align Technology's stock price to reach $586.20 in the next twelve months. This suggests a possible upside of 142.1% from the stock's current price.
View analysts' price targets for Align Technology
or view top-rated stocks among Wall Street analysts.

How has Align Technology's stock price performed in 2022?

Align Technology's stock was trading at $657.18 at the beginning of 2022. Since then, ALGN shares have decreased by 63.2% and is now trading at $242.15.
View the best growth stocks for 2022 here

When is Align Technology's next earnings date?

Align Technology is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022.
View our earnings forecast for Align Technology

How were Align Technology's earnings last quarter?

Align Technology, Inc. (NASDAQ:ALGN) posted its quarterly earnings results on Wednesday, April, 27th. The medical equipment provider reported $1.70 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.99 by $0.29. The medical equipment provider had revenue of $973.22 million for the quarter, compared to the consensus estimate of $1 billion. Align Technology had a net margin of 17.51% and a trailing twelve-month return on equity of 19.90%. During the same quarter in the previous year, the firm earned $2.51 EPS.
View Align Technology's earnings history

Who are Align Technology's key executives?

Align Technology's management team includes the following people:

What is Joe Hogan's approval rating as Align Technology's CEO?

346 employees have rated Align Technology CEO Joe Hogan on Glassdoor.com. Joe Hogan has an approval rating of 97% among Align Technology's employees. This puts Joe Hogan in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Align Technology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), PayPal (PYPL), Micron Technology (MU), Adobe (ADBE), Visa (V), Salesforce (CRM), Mastercard (MA) and Tesla (TSLA).

What is Align Technology's stock symbol?

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

How do I buy shares of Align Technology?

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Align Technology's stock price today?

One share of ALGN stock can currently be purchased for approximately $242.15.

How much money does Align Technology make?

Align Technology (NASDAQ:ALGN) has a market capitalization of $19.08 billion and generates $3.95 billion in revenue each year. The medical equipment provider earns $772.02 million in net income (profit) each year or $8.89 on an earnings per share basis.

How many employees does Align Technology have?

Align Technology employs 22,540 workers across the globe.

Does Align Technology have any subsidiaries?

The following companies are subsidiares of Align Technology: Align Technology Switzerland GmbH, Cadent, G.L. Dental Couture, and exocad Global Holdings GmbH (“exocad”).
Read More

When was Align Technology founded?

Align Technology was founded in 1997.

How can I contact Align Technology?

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The official website for Align Technology is www.aligntech.com. The medical equipment provider can be reached via phone at (408) 470-1000, via email at [email protected], or via fax at 408-470-1010.

This page (NASDAQ:ALGN) was last updated on 6/30/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.